Ning Xi

A Soluble Base for the Copper-Catalyzed Imidazole N-Arylations with Aryl Halides

Longbin Liu, Mike Frohn, Ning Xi et al. · The Journal of Organic Chemistry · 2005 · 172 citations

Discovery and Optimization of a Series of Benzothiazole Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitors

Noel D. D’Angelo, Tae‐Seong Kim, Kristin L. Andrews et al. · Journal of Medicinal Chemistry · 2011 · 118 citations · Full text

Drug Target, Pharmacotherapy, Benzothiazole Phosphoinositide 3-Kinase +21

Nitrogen Heterocycles From Furans: The Aza-Achmatowicz Reaction

Marco A. Ciufolini, Cynthia Y. W. Hermann, Qing Dong et al. · Synlett · 1998 · 116 citations

Aza-achmatowicz Reaction, Engineering, Heterocyclic +11

Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives

Mark H. Norman, Longbin Liu, Matthew Lee et al. · Journal of Medicinal Chemistry · 2012 · 101 citations · Full text

Combinatorial Chemistry, Class Ii, Drug Target +18

Discovery of a Potent, Selective, and Orally Bioavailable c-Met Inhibitor: 1-(2-Hydroxy-2-methylpropyl)-<i>N</i>-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazole-4-carboxamide (AMG 458)

Longbin Liu, Aaron Siegmund, Ning Xi et al. · Journal of Medicinal Chemistry · 2008 · 94 citations · Full text

Pharmaceutical Science, Metabolic Hot Spot, Chemoprevention Strategy +21